Literature DB >> 15958830

The potential for interactions between antimalarial and antiretroviral drugs.

Saye Khoo, David Back, Peter Winstanley.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 15958830     DOI: 10.1097/01.aids.0000174445.40379.e0

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  43 in total

Review 1.  Unresolved antiretroviral treatment management issues in HIV-infected children.

Authors:  Shirin Heidari; Lynne M Mofenson; Charlotte V Hobbs; Mark F Cotton; Richard Marlink; Elly Katabira
Journal:  J Acquir Immune Defic Syndr       Date:  2012-02-01       Impact factor: 3.731

Review 2.  Clinical pharmacokinetic drug interactions associated with artemisinin derivatives and HIV-antivirals.

Authors:  Tony K L Kiang; Kyle J Wilby; Mary H H Ensom
Journal:  Clin Pharmacokinet       Date:  2014-02       Impact factor: 6.447

3.  Persistent high nevirapine blood level with DRESS syndrome 12 days after interruption of antiretroviral therapy.

Authors:  Alice Breining; Amelie Guihot; Dominique Warot; Ana Canestri; Gilles Peytavin; Francois Bricaire; Eric Caumes
Journal:  BMJ Case Rep       Date:  2009-03-17

Review 4.  A Review of the Toxicity of HIV Medications II: Interactions with Drugs and Complementary and Alternative Medicine Products.

Authors:  Andrew Stolbach; Karolina Paziana; Harry Heverling; Paul Pham
Journal:  J Med Toxicol       Date:  2015-09

5.  Interaction between artemether-lumefantrine and nevirapine-based antiretroviral therapy in HIV-1-infected patients.

Authors:  T Kredo; K Mauff; J S Van der Walt; L Wiesner; G Maartens; K Cohen; P Smith; K I Barnes
Journal:  Antimicrob Agents Chemother       Date:  2011-09-26       Impact factor: 5.191

6.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

7.  Asexual and sexual stages of Plasmodium falciparum in Nigerian pregnant women attending antenatal booking clinic.

Authors:  S T Balogun; F A Fehintola; O A Adeyanju; A A Adedeji
Journal:  Obstet Med       Date:  2010-09-17

8.  Effect of single nucleotide polymorphisms in cytochrome P450 isoenzyme and N-acetyltransferase 2 genes on the metabolism of artemisinin-based combination therapies in malaria patients from Cambodia and Tanzania.

Authors:  Eva Maria Staehli Hodel; Chantal Csajka; Frédéric Ariey; Monia Guidi; Abdunoor Mulokozi Kabanywanyi; Socheat Duong; Laurent Arthur Decosterd; Piero Olliaro; Hans-Peter Beck; Blaise Genton
Journal:  Antimicrob Agents Chemother       Date:  2012-12-10       Impact factor: 5.191

9.  Update on the efficacy, effectiveness and safety of artemether-lumefantrine combination therapy for treatment of uncomplicated malaria.

Authors:  Pauline Byakika-Kibwika; Mohammed Lamorde; Harriet Mayanja-Kizza; Concepta Merry; Bob Colebunders; Jean-Pierre Van Geertruyden
Journal:  Ther Clin Risk Manag       Date:  2010-02-02       Impact factor: 2.423

10.  A microarray-based system for the simultaneous analysis of single nucleotide polymorphisms in human genes involved in the metabolism of anti-malarial drugs.

Authors:  Eva Maria Hodel; Serej D Ley; Weihong Qi; Frédéric Ariey; Blaise Genton; Hans-Peter Beck
Journal:  Malar J       Date:  2009-12-09       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.